152 related articles for article (PubMed ID: 388470)
1. Prostacyclin (PGI2) and the effect of phosphodiesterase inhibitors on platelet aggregation.
Jørgensen KA; Dyerberg J; Stoffersen E
Pharmacol Res Commun; 1979 Jul; 11(7):605-15. PubMed ID: 388470
[No Abstract] [Full Text] [Related]
2. A biphasic effect of prostacyclin (PGI2) on platelet aggregation.
Jørgensen KA; Dyerberg J; Stoffersen E
Thromb Res; 1980 Sep; 19(6):877-81. PubMed ID: 6258262
[No Abstract] [Full Text] [Related]
3. Effect of prostacyclin on platelet-activating factor induced rabbit and platelet aggregation.
Bussolino F; Camussi G
Prostaglandins; 1980 Nov; 20(5):781-91. PubMed ID: 6258196
[TBL] [Abstract][Full Text] [Related]
4. Enhanced prostacyclin production by dipyridamole in man.
Neri Serneri GG; Masotti G; Poggesi L; Galanti G; Morettini A
Eur J Clin Pharmacol; 1981; 21(1):9-15. PubMed ID: 7037426
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species.
Whittle BJ; Moncada S; Vane JR
Prostaglandins; 1978 Sep; 16(3):373-88. PubMed ID: 364545
[TBL] [Abstract][Full Text] [Related]
6. Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin.
Moncada S; Korbut R
Lancet; 1978 Jun; 1(8077):1286-9. PubMed ID: 78050
[TBL] [Abstract][Full Text] [Related]
7. Effects of PGI2 on platelet aggregation induced by various stimulants.
Ohtsu A; Hoshina K; Kurozumi S; Hashimoto Y; Noguchi T; Nicolaou KC
Nihon Ketsueki Gakkai Zasshi; 1979 Aug; 42(4):659-66. PubMed ID: 388963
[No Abstract] [Full Text] [Related]
8. Heparin neutralization of PGI2: effects upon platelets.
Saba HI; Saba SR; Blackburn CA; Hartmann RC; Mason RG
Science; 1979 Aug; 205(4405):499-501. PubMed ID: 377493
[TBL] [Abstract][Full Text] [Related]
9. Effects of prostacyclin, 6-keto-PGF1 alpha PGF2 alpha and 15[S]15-methyl-PGF2 alpha on platelet aggregation in vitro.
Marmo E; Somma A; Ottavo R; Vairo G; Spaziante G; DiMezza F; Paone G
J Med; 1981; 12(2-3):97-108. PubMed ID: 7024451
[No Abstract] [Full Text] [Related]
10. Platelet sensitivity to adenosine diphosphate and to prostacyclin in diabetic patients.
Onodera H; Hirata T; Sugawara H; Sugai K; Yoda B; Toyota T; Goto Y
Tohoku J Exp Med; 1982 Aug; 137(4):423-8. PubMed ID: 6750843
[TBL] [Abstract][Full Text] [Related]
11. Effects of intravenous epoprostenol on platelets and the cardiovascular system are not potentiated by dipyridamole.
Pickles H; Fish A; Hassan S; Burke C; Warrington S; O'Grady J
Clin Pharmacol Ther; 1983 Feb; 33(2):178-82. PubMed ID: 6337004
[TBL] [Abstract][Full Text] [Related]
12. The generation of TXA2 in human platelet rich plasma and its inhibition by nictindole and prostacyclin.
Grodzińska L; Marcinkiewicz E
Pharmacol Res Commun; 1979 Feb; 11(2):133-46. PubMed ID: 375247
[No Abstract] [Full Text] [Related]
13. Role of cyclic AMP in the inhibition of human platelet aggregation by quercetin, a flavonoid that potentiates the effect of prostacyclin.
Beretz A; Stierle A; Anton R; Cazenave JP
Biochem Pharmacol; 1982 Nov; 31(22):3597-600. PubMed ID: 6295405
[TBL] [Abstract][Full Text] [Related]
14. [Platelet sensitivity to prostacyclin (PGI2) in patients with juvenile-onset diabetes mellitus (author's transl)].
Klein K; Sinzinger H; Schernthaner G; Silberbauer K; Prager R
Wien Klin Wochenschr; 1981 Jul; 93(14):460-2. PubMed ID: 7023074
[TBL] [Abstract][Full Text] [Related]
15. Prostacyclin inhibits mobilisation of fibrinogen-binding sites on human ADP- and thrombin-treated platelets.
Hawiger J; Parkinson S; Timmons S
Nature; 1980 Jan; 283(5743):195-7. PubMed ID: 6985716
[TBL] [Abstract][Full Text] [Related]
16. Combined effect of prostaglandins and an aortic proteoglycan on platelet aggregation and plasma clotting.
Ts'ao C; Eisenstein R
Prostaglandins Med; 1979 Sep; 3(3):159-66. PubMed ID: 399532
[TBL] [Abstract][Full Text] [Related]
17. Anti-platelet aggregating and disaggregating activities of 6,9-methano PGI2.
Morita A; Mori M; Hasegawa K; Kojima K; Kobayashi S
Life Sci; 1980 Aug; 27(8):695-701. PubMed ID: 6997669
[No Abstract] [Full Text] [Related]
18. The effect of PGI2 and theophylline on the response of platelets subjected to shear stress.
Hardwick RA; Hellums JD; Peterson DM; Moake JL; Olson JD
Blood; 1981 Oct; 58(4):678-81. PubMed ID: 7023570
[TBL] [Abstract][Full Text] [Related]
19. Platelets of spontaneously hypertensive rats are not abnormally sensitive to PGI2.
Botha JH; Leary WP
Prostaglandins Med; 1981 Dec; 7(6):499-500. PubMed ID: 7034022
[No Abstract] [Full Text] [Related]
20. Potentiation of anti-aggregating activity of PGI2 by 7-ethoxycarbonyl-6,8-dimethyl-4-hydroxymethyl-1(2H)-phthalazinone (EG-626) in rabbit platelets in vitro.
Tanaka K; Harada Y; Iwata M; Katori M
Prostaglandins; 1980 Aug; 20(2):255-68. PubMed ID: 6997930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
